Advertising executive and author Lois Wyse died Friday at her Manhattan home of stomach cancer. She was 80.

Perhaps best known for her famous slogan, With a name like Smucker's, it has to be good, Wyse -- who founded Wyse Advertising with her first husband Marc and went on to win the J.M. Smucker Company account -- was also the brains behind this name: Bed, Bath & Beyond. The small retail chain began as Bed and Bath. Wyse thought it would fare better with a more complete name.

Wyse was a powerful woman in business. Her company was chosen to create the first television advertising campaign for New Woman magazine. She was was the first woman on the board of the Consolidated Natural Gas Company and the Higbee Company, and she was a founding member of both the Committee of 200, a group of women with executive jobs, and of Catalyst, a women's research organization.

The Colorectal Cancer Coalition will visit the New York Stock Exchange tomorrow -- Monday, March 5, 2007 -- and will ring in the start of the business day.

Executive director Carlea Bauman will ring the NYSE Opening Bell in honor of Colorectal Cancer Awareness Month, and you don't have to be in New York to witness the wonder of it all. Just click here and follow instructions for viewing a live webcast of The Opening Bell. It all begins at 9:25 AM Eastern Standard Time. You can also tune it to CNBC for coverage of the event.

The Colorectal Cancer Coalition, also known as C3 and headquartered in Washington DC, pushes for research to improve screening, diagnosis, and treatment of colorectal cancer; for policy decisions that make the most effective colon and rectal cancer prevention and treatment available to all; and for increased awareness that colorectal cancer is preventable, treatable, and beatable.

Merck, maker of the cervical cancer vaccine Gardasil, is backing off its lobbying campaign following pressure from medical groups and parents who believe the vaccine should not be mandated as a school attendance requirement for adolescent girls.

The public outcry that caused Merck to announce its stop order on Tuesday stems from the fact that the vaccine protects against the sexually transmitted human papilloma virus (HPV), which causes cervical cancer. School-mandated vaccines are typically for diseases spread through casual contact, such as measles and mumps.

Merck's medical director for vaccines, Dr. Richard M. Haupt says, "We're concerned that our role in supporting school requirements is a distraction from that goal, and as such have suspended our lobbying efforts," adding that the company will continue providing information about the vaccine upon request.

Gardasil, launched in June and the first vaccine to prevent cervical cancer, has inspired controversy since day one. There's the cost -- $360 for three required shots -- and all sorts of insurance concerns and conservative groups who worry the vaccine encourages premarital sex and interferes with parental rights. Even those in support of the vaccine -- like the American Academy of Pediatrics and the American Academy of Family Practitioners -- question Merck's quick push to market this drug, especially in light of the company's withdrawn painkiller Vioxx.

"I believe that their timing was a little bit premature so soon after (Gardasil's) release, before we have a picture of whether there are going to be any untoward side effects," says Dr. Anne Francis, who chairs an American Academy of Pediatrics committee.

Legislatures in 20 states have taken steps to mandate the vaccine for young girls. And with the exception of Texas governor Rick Perry's February 2 executive order requiring Texas girls entering the sixth grade in 2008 get vaccinated, nothing has been made official so far.

Living Beyond Breast Cancer (LBBC) -- a nonprofit organization dedicated to empowering all women affected by breast cancer to live as long as possible with the best quality of life -- recently began offering a new resource for breast cancer survivors, for both the newly diagnosed and those with metastatic disease.

"The first few weeks after diagnosis can be extremely difficult emotionally, and women with advanced disease often do not get the support and resources they need," said Jean Sachs, LBBC executive director. "We want to give them an understanding of their choices to help them make informed decisions regarding their physical and emotional health."

This understanding comes in the form of a 28-page brochure -- What to expect . . . today, tomorrow and beyond: Steps for coping with the medical, emotional and practical concerns of breast cancer -- available free on the Internet or by request. This guide, a road map, addresses topics such as coping with the news of a new diagnosis, telling family and friends, understanding pathology reports, choosing a medical team, asking for help, and finding support.

LBBC offers multiple addidtional resources -- including specialized navigation tools on its website that lead to a wealth of information. Visitors can Learn More about LBBC. They can Stay Informed through news, message boards, and other resources. They can Participate in events and programs. And they can Support LBBC through volunteer efforts and financial donations.

LBBC was founded in 1991 by a radiation oncologist who focused exclusively on meeting the needs of women post-treatment. She ran the organization out of the third floor of her home using volunteers. Few resources existed for women affected by breast cancer at the time, and so she tried to fill the void. In 1986, an executive director came on board, increased the LBBC budget from $100,000 to $1.8 million per year, expanded all programs and services, and worked to secure LBBC as a solid, dependable resource for all women, of all stages of breast cancer and in all phases of treatment and recovery. And now, in 2006, that is exactly what it is.

Dealing with cancer in private is hard. Dealing with cancer publicly can be even harder. CEO Donna McAleer -- the founding executive and public face of the large, growing health care company Elant -- knows this firsthand. She just recently went public with her breast cancer diagnosis and prognosis after rumors of her demise started circulating. McAleer set the record straight, announcing that she is doing just fine. While her experience has been frightening, she is surviving well -- and she wants the public to know. She has run Elant for 20 years and wants to dispel any myths about its stability. Apple CEO Steve Jobs faced the same public drama in 2004 after surgery for pancreatic cancer and subsequent drops in Apple stock. Jobs recovered -- and so did the stock -- but the speculation that swirled was powerful and potentially damaging. Just as it was that same year when Kraft Foods was criticized for withholding details of its CEO's hospitalization.

There is some debate in the business world about all of this -- about whether or not executive illnesses should be disclosed. For public companies, one opinion is that there is an obligation to respond quickly to the public. In a private company, it's up to the CEO. McAleer's Elant is not a publicly traded company and there is no worry about stock price -- but her decision to reveal her personal health crisis was the right thing to do, she says. "I have an obligation to share this news in how I progress, in order to educate and make sure people aren't frightened by it," she said in reference to the memo she sent to her 700 employees and community groups too.

I'm open and honest about my own cancer experience because I believe it can help others -- and it helps me to talk about it too. So I'm a fan of a forthcoming approach in the workplace. I appreciate that some fear repercussions that might result from such a disclosure. But honesty may be the best policy -- for prevention of rumors and addressing worry and raising awareness too. McAleer seems to agree as she takes this opportunity to speak up, to encourage women to seek mammograms and to follow up on them.